Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Non-cash Items (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Non-cash Items over the past 10 years, most recently at $20.2 million for Q4 2023.

  • For Q4 2023, Non-cash Items rose 5537.31% year-over-year to $20.2 million; the TTM value through Dec 2023 reached $20.2 million, up 5537.31%, while the annual FY2023 figure was $20.2 million, 5537.31% up from the prior year.
  • Non-cash Items for Q4 2023 was $20.2 million at Corbus Pharmaceuticals Holdings, down from $20.8 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $38.8 million in Q3 2021 and troughed at $358611.0 in Q4 2022.
  • A 5-year average of $20.0 million and a median of $20.5 million in 2023 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: tumbled 96.02% in 2022 and later surged 5537.31% in 2023.
  • Year by year, Non-cash Items stood at $7.8 million in 2019, then tumbled by 55.33% to $3.5 million in 2020, then soared by 157.42% to $9.0 million in 2021, then tumbled by 96.02% to $358611.0 in 2022, then surged by 5537.31% to $20.2 million in 2023.
  • Business Quant data shows Non-cash Items for CRBP at $20.2 million in Q4 2023, $20.8 million in Q3 2023, and $20.8 million in Q2 2023.